ClinicalTrials.gg
CompletedNCT07948642ESWLUpdated Nov 19, 2026

Virtual Reality for Pain and Comfort During ESWL for Urinary Tract Stones

An interventional study of Audiovisual Virtual Reality Distraction in Urolithiasis and Procedural Pain, sponsored by Burdur Mehmet Akif Ersoy University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Burdur Mehmet Akif Ersoy University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2026, registered Oct 2026).
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Urolithiasis with a site in Turkey — 10 open to participants now, 10 under way, none of them phase 3. Urolithiasis · Turkey.

Enrollment
12th of 17
67 · median 80
Started
2026
with 8 others
No phase
15 of 27
3 open now
Registered
27th of 27
by date
Lead sponsor
1 of 27
Burdur Mehmet Akif Ersoy University

Among the 27 studies in Urolithiasis with a site in Turkey, this one is the 12th largest by enrollment of the 17 interventional ones that give a count, is one of 9 that started in 2026, is one of 15 with no phase, and was the 27th registered.

Urolithiasis

257 studies on the registry are indexed under Urolithiasis; 69 are open to participants now.

Browse Urolithiasis studies →

Open to participants now

10 of the 27 studies in Urolithiasis with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 38 Urolithiasis studies recruiting now, 18 (47%) set no upper age limit and 12 (32%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Urolithiasis with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this study was to learn whether virtual reality could reduce pain and improve comfort during shock wave treatment for urinary tract stones. This treatment is called extracorporeal shock wave lithotripsy (ESWL). It uses shock waves from outside the body to break stones into smaller pieces.

The main questions were:

  • Did participants who used virtual reality report less pain than those who received usual care alone?
  • Did participants who used virtual reality feel more comfortable?
  • Did virtual reality affect vital signs, such as heart rate and blood pressure? The study included 65 adults aged 18 years or older who underwent their first ESWL treatment at Burdur State Hospital in Türkiye.

Participants were assigned by chance to one of two groups. One group used a virtual reality headset to watch a nature-themed video with sound during treatment. This group also received usual care. The other group received usual care without virtual reality.

Participants in both groups rated their pain and comfort from 0 to 10 before and after treatment. The research team also measured their vital signs at these times.

The study compared these measures between the two groups to assess the effects of adding virtual reality to usual care.

Read the detailed description

Pain and discomfort during extracorporeal shock wave lithotripsy may affect patients' experience of treatment. Audiovisual virtual reality provides an immersive distraction that may shift attention away from the procedure. This study evaluated virtual reality as a nonpharmacological nursing intervention, with a focus on patient-reported pain and comfort and physiological responses to treatment.

A computer-generated allocation sequence was created using Research Randomizer to assign participants to the intervention or control group. The virtual reality content consisted of a nature-themed video with sound selected by the research team. The intervention was delivered during the ESWL session.

A structured patient information form was used to record demographic and clinical characteristics relevant to the treatment experience. These included age, sex, body mass index, stone size, stone location, skin-to-stone distance, and stone density. Assessments were conducted at corresponding stages of care in both groups to support comparison of their responses.

The evaluation focused on differences between groups and changes from before to after ESWL. The study hypothesis was that participants receiving audiovisual virtual reality would report less pain and greater comfort than participants receiving routine care alone. Vital signs were assessed to explore the physiological effects associated with the intervention.

03

Conditions studied

  • Urolithiasis
  • Procedural Pain

Keywords

  • Urolithiasis
  • Extracorporeal Shock Wave Lithotripsy
  • ESWL
  • Virtual Reality
  • Audiovisual Distraction
  • Procedural Pain
  • Patient Comfort
  • Vital Signs
  • Nonpharmacological Pain Management
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • Diagnosed with urinary tract stones and scheduled to undergo extracorporeal shock wave lithotripsy (ESWL)
  • Able to read and write in Turkish
  • Willing to participate and provide

Exclusion criteria

Exclusion Criteria:

  • Previous ESWL treatment
  • A psychiatric disorder
  • Cognitive or perceptual impairment that prevents understanding study instructions or completing assessments
  • Visual or hearing impairment that prevents participation in the audiovisual virtual reality intervention
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    Virtual Reality Plus Routine Care

    Participants received routine care and watched a nature-themed video with sound through a virtual reality headset during extracorporeal shock wave lithotripsy (ESWL).

    Behavioral: Audiovisual Virtual Reality Distraction

  • No intervention
    Routine Care

    Participants received routine care during extracorporeal shock wave lithotripsy (ESWL), without virtual reality or an additional study-specific distraction intervention.

Interventions

  • BehavioralAudiovisual Virtual Reality Distraction

    Participants watched a nature-themed video with accompanying sound through a virtual reality headset during extracorporeal shock wave lithotripsy (ESWL). The audiovisual content was selected by the research team and provided as a distraction intervention in addition to routine care.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Participants rated their pain intensity immediately after ESWL on a scale ranging from 0 (no pain) to 10 (worst pain). Higher scores indicated greater pain intensity. Scores were compared between the virtual reality and routine care groups.

    Time frame: Immediately after completion of ESWL on Day 1.

Secondary outcomes

  1. Patient Comfort

    Participants rated their comfort immediately after ESWL on a scale ranging from 0 to 10. Higher scores indicated greater comfort. Scores were compared between the virtual reality and routine care groups.

    Time frame: Immediately after completion of ESWL on Day 1.

  2. Systolic Blood Pressure

    Systolic blood pressure was recorded in millimeters of mercury (mmHg) before and after ESWL. Measurements were compared between the virtual reality and routine care groups.

    Time frame: Periprocedural (Day 1: before the start of ESWL and after completion of ESWL).

  3. Diastolic Blood Pressure

    Diastolic blood pressure was recorded in millimeters of mercury (mmHg) before and after ESWL. Measurements were compared between the virtual reality and routine care groups.

    Time frame: Periprocedural (Day 1: before the start of ESWL and after completion of ESWL).

  4. Pulse Rate

    Pulse rate was recorded in beats per minute before and after ESWL. Measurements were compared between the virtual reality and routine care groups.

    Time frame: Periprocedural (Day 1: before the start of ESWL and after completion of ESWL).

07

Study locations

1 site
  • Burdur Mehmet Akif Ersoy University
    Burdur, Burdur 15030, Turkey (Türkiye)
08

References and documents

Publications

  • Mediani HS, Hendrawati S, Sukmawati S, Nurhidayah I. Virtual Reality for Managing Procedural Pain in Children: A Concept Analysis with Walker and Avant Approach. J Pain Res. 2026 Aug 15;19:595256. doi: 10.2147/JPR.S595256. eCollection 2026. PubMed 42621612 ↗
  • Albazee E, Alrajehi A, Alsahli FM, Alqemlas A, Aldhaen A, Alkandari A, Alkandari H, Alkanderi W. Virtual Reality Distraction for Reducing Pain and Anxiety During Percutaneous Cardiovascular Interventions: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. Medicina (Kaunas). 2025 May 22;61(6):957. doi: 10.3390/medicina61060957. PubMed 40572646 ↗
  • Gupta NP, Kumar A. Analgesia for pain control during extracorporeal shock wave lithotripsy: Current status. Indian J Urol. 2008 Apr;24(2):155-8. doi: 10.4103/0970-1591.40607. PubMed 19468389 ↗
  • Lambert V, Boylan P, Boran L, Hicks P, Kirubakaran R, Devane D, Matthews A. Virtual reality distraction for acute pain in children. Cochrane Database Syst Rev. 2020 Oct 22;10(10):CD010686. doi: 10.1002/14651858.CD010686.pub2. PubMed 33089901 ↗
  • Tashjian VC, Mosadeghi S, Howard AR, Lopez M, Dupuy T, Reid M, Martinez B, Ahmed S, Dailey F, Robbins K, Rosen B, Fuller G, Danovitch I, IsHak W, Spiegel B. Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial. JMIR Ment Health. 2017 Mar 29;4(1):e9. doi: 10.2196/mental.7387. PubMed 28356241 ↗
  • Besirik Y, Sayar S. The Effect of Virtual Reality on Anxiety and Vital Signs in Patients Undergoing Total Knee Replacement Surgery: A Randomized Controlled Trial. Comput Inform Nurs. 2026 Mar 13. doi: 10.1097/CIN.0000000000001515. Online ahead of print. PubMed 41824967 ↗
  • Quara A, Candela L, Madden A, Corrales M, Cabrera J, Moretto S, Ventimiglia E, Panthier F, Doizi S, Traxer O. The use of a virtual reality device (HypnoVR(R)) during extracorporeal shockwave lithotripsy for urinary stones: A case-control study. Fr J Urol. 2025 Jun;35(5):102871. doi: 10.1016/j.fjurol.2025.102871. Epub 2025 Feb 19. PubMed 39983906 ↗
  • Candela L, Ventimiglia E, Corrales M, Sierra Del Rio A, Villa L, Goumas IK, Salonia A, Montorsi F, Doizi S, Traxer O. The Use of a Virtual Reality Device (HypnoVR) During Extracorporeal Shockwave Lithotripsy for Treatment of Urinary Stones: Initial Results of a Clinical Protocol. Urology. 2023 May;175:13-17. doi: 10.1016/j.urology.2023.01.048. Epub 2023 Feb 15. PubMed 36796544 ↗
  • Rothman KF. Laser surgery for children. J Dermatol Surg Oncol. 1987 Nov;13(11):1158. No abstract available. PubMed 3668057 ↗
  • Çelik, D., & Güneş, A. (2025). The effect of virtual reality glasses on pain and anxiety during the kidney stone lithotripsy procedure. Health Sciences Quarterly, 5(3), 233-241. https://doi.org/10.26900/hsq.2712
  • Chan E, Foster S, Sambell R, Leong P. Clinical efficacy of virtual reality for acute procedural pain management: A systematic review and meta-analysis. PLoS One. 2018 Jul 27;13(7):e0200987. doi: 10.1371/journal.pone.0200987. eCollection 2018. PubMed 30052655 ↗
  • Pourmand A, Davis S, Marchak A, Whiteside T, Sikka N. Virtual Reality as a Clinical Tool for Pain Management. Curr Pain Headache Rep. 2018 Jun 15;22(8):53. doi: 10.1007/s11916-018-0708-2. PubMed 29904806 ↗
  • Malloy KM, Milling LS. The effectiveness of virtual reality distraction for pain reduction: a systematic review. Clin Psychol Rev. 2010 Dec;30(8):1011-8. doi: 10.1016/j.cpr.2010.07.001. Epub 2010 Jul 13. PubMed 20691523 ↗
  • EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam, 2022. ISBN 978-94-92671-16-5. Erişim Linki: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.nemcb.cz/files/hvvv/4/1671566870_Skolarikos-2022-EAU%20Guidelines%20on%20Urolithiasis.pdf
  • Bozkurt, M., Yıldız, Y., Kaya, E., & Özgür, B. C. (2022). The effect of listening to music on reducing anxiety and pain during extracorporeal shock-wave lithotripsy: A randomized controlled study. Haseki Medical Journal, 60(3), 1-7. https://doi.org/10.4274/haseki.galenos.2022.8728

Individual participant data

Plan to share: No — There is no plan to share individual participant data with other researchers. Study findings will be disseminated through scientific publications in aggregate form, without identifying individual participants.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Oct 2026, 8 months.

Of 88 non-industry interventional studies with no phase under Urolithiasis, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's 8 months is below that.

Counting every sponsor, half of 98 studies reached it within 19 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Nov 19, 2026
StartActual
Jan 20, 2026
Primary completionActual
Oct 10, 2026
CompletionActual
Nov 12, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948642
Lead sponsor
Burdur Mehmet Akif Ersoy University
Responsible party
Kübra Yasak (Assistant Professor, Burdur Mehmet Akif Ersoy University) — Principal investigator
First posted
Nov 19, 2026
Start date
Jan 20, 2026
Primary completion
Oct 10, 2026
Completion
Nov 12, 2026
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion